#United States #Hanover #Brain Aneurysm Foundation #Joseph P. Caruso #Katelyn's Crew

Joseph P. Caruso Appointed to the Brain Aneurysm Foundation Board

The Brain Aneurysm Foundation (BAF), recognized as a leading institution in the area of brain aneurysm advocacy and research, has announced the appointment of Joseph P. Caruso to its Board of Directors. Mr. Caruso, a seasoned healthcare executive with extensive experience in the medical device industry, will serve a three-year term starting in January 2025. This significant step aims to strengthen the foundation’s mission of educating the public and medical professionals about brain aneurysms, encouraging research, and ultimately preventing the devastating effects of this condition.

With over 20 years at the helm of Palomar Medical Technologies, where he held titles such as President, CEO, and Board Chairman, Mr. Caruso brings a wealth of operational and managerial expertise to the BAF. His extensive background in healthcare leadership is seen as a cornerstone in the foundation’s efforts to enhance initiatives dealing with brain aneurysm awareness and education.

Tragedy struck Mr. Caruso's family in 2023 when they lost their daughter, Katelyn, to a brain aneurysm at the young age of 31. In memory of Katelyn, the Carusos founded "Katelyn's Crew," an organization dedicated to raising awareness around brain aneurysms and funding two research chairs at prestigious institutions including Mass General Brigham and the University of Pittsburgh. This personal journey reflects their commitment to transforming the landscape of brain aneurysm research and education.

Christine Buckley, Executive Director of the BAF, expressed her enthusiasm for Mr. Caruso’s arrival, stating, "The Carusos have been tireless in their work to create awareness and to fund research that can accelerate new treatments and interventions for brain aneurysms." She emphasizes how critical it is to educate those at risk and those who can intervene, including physicians and first responders.

As part of his role, Mr. Caruso expressed a firm commitment to collaborating with fellow board members and the greater community to thwart the preventable occurrences of ruptured brain aneurysms. "We are on the verge of significant advancements to better detect and predict potential ruptures, and with additional resources, we will be able to expedite life-saving treatments," he stated.

The urgency of Mr. Caruso's mission is underscored by statistics indicating that one in fifty individuals in the U.S. has a brain aneurysm, with an alarming estimate of 30,000 ruptures occurring each year, half of which are fatal. Globally, close to 500,000 deaths each year result from brain aneurysms, with a troubling number of these fatalities occurring in individuals under 50.

A brain aneurysm is characterized as a weakened, bulging section of an artery in the brain that can rupture, leading to a serious type of stroke called a subarachnoid hemorrhage. Most prevalent in individuals aged 35 to 60, brain aneurysms can also occur in children and pose a particularly heightened risk for women over 55.

The Brain Aneurysm Foundation, established in 1994 and based in Hanover, Massachusetts, dedicates itself to increasing awareness regarding the symptoms and risks of brain aneurysms to minimize the chances of rupture. The foundation collaborates with medical communities to support patients and families, and to advance pivotal research aimed at improving outcomes.

Led by a Medical Advisory Board that includes more than 40 leading experts in the field, the organization continues its mission to save lives and offer resources for those affected by this cruel condition. For more information, you can visit the Brain Aneurysm Foundation's official website and follow them across various social media platforms.